A series of resveratrol derivatives were discovered as novel LSD1 inhibitors. Most compounds exhibited potent inhibitory activities against recombinant LSD1. Compounds 4e and 4m elevated the level of H3K4Me2 significantly in MGC-803 cells. Compounds 4e and 4m increased the expression level of CD86 mRNA in MGC-803 cells.